MMP2 and neoplasm: Elevated MMP-2 [5,94] and MMP-9 [95] levels in patient tissue samples, serum, or cerebrospinal fluid (CSF) have been associated with advanced tumor grades, an increased risk of recurrence, and lower overall survival.